고 에너지 방사선치료 시 GEANT4-DICOM과 TPS간 선량비교 연구
A Comparative Study on the Dose of GEANT4-DICOM to TPS for High-Energy Radiation Treatment
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Radiation therapy is one of the beneficial choices in the treatment of cancer. This is a comparison of TPS(Treatment Planning System) and GEANT4-DICOM, which should be preceded by the best radiation therapy. A treatment plan for prostate cancer was established with Eclipse and the point doses 366.1 cGy, 189.1 cGy, 213.4 cGy, 127 cGy, 105.7 cGy of any five prostate, bladder, rectum, right femoral head and left femoral head were identified. GEANT4-DICOM simulation showed that the results of Eclipse and ± 2% dose error were confirmed. The monthly X-ray output agreement management value recommended by TG-142 is ± 2%, which means that the experimental results can be meaningful. In conclusion, GEANT4-DICOM is an infinite way to obtain more extended dose information once the time constraints are overcome in the simulation.
Abstract
Radiation therapy is one of the beneficial choices in the treatment of cancer. This is a comparison of TPS(Treatment Planning System) and GEANT4-DICOM, which should be preceded by the best radiation therapy. A treatment plan for prostate cancer was established with Eclipse and the point doses 366.1 cGy, 189.1 cGy, 213.4 cGy, 127 cGy, 105.7 cGy of any five prostate, bladder, rectum, right femoral head and left femoral head were identified. GEANT4-DICOM simulation showed that the results of Eclipse and ± 2% dose error were confirmed. The monthly X-ray output agreement management value recommended by TG-142 is ± 2%, which means that the experimental results can be meaningful. In conclusion, GEANT4-DICOM is an infinite way to obtain more extended dose information once the time constraints are overcome in the simulation.
참고문헌 (17)
- Murray LJ, "Radiotherapy : technical aspects", Medicine, 44(1), pp.10~14 (2016)
- Mazonakis M, "Cancer risk after radiotherapy for benign diseases", Physica Medica, 42, pp.285~291 (2017)
- Ortega JFC, "A dosimetric evaluation of the Eclipse AAA algorithm and Millennium 120 MLC for cranial intensity-modulated radiosurgery", Medical Dosimetry, 39(2), pp.129~133 (2014)
- Papadimitroulas P, "Dosimetry applications in GATE Monte Carlo toolkit", Physica Medica, 41, pp.136~140 (2017)
- Howell RM, "Effects of tertiary MLC configuration on secondary neutron spectra from 18 MV x-ray beams for the varian 21EX linear accelerator", Med Phys, 36, pp.4039~4046 (2009)
- 강세권, "제작된 선량 검증용 IMRT 팬텀의 몬테칼로 시뮬레이션 : 예비적 연구", 의학물리, 18(3), pp.126~133 (2007), 한국의학물리학회
- Kim HK, "Monte Carlo simulation of the photon beam characteristics from medical linear accelerators", Radiation Protection Dosimetry, 119, pp.510~513 (2006)
- 강상구, "몬테카를로 방법에 의한 6MV 선형가속기의 광자 흡수선량 분포 평가에 관한 연구", 방사선기술과학, 34(1), pp.43~50 (2011), 대한방사선과학회
- Mildenberger P, "Introduction to the DICOM standard", Eur Radiol, 12, pp.920~927 (2001)
- Bidgood WD, "Understanding and Using DICOM, the data Interchange Standard for Biomedical Imaging", J Am Med Inform Assoc, 4, pp.199~212 (1997)
- 이상호, "유방촬영에서 Geant4 시뮬레이션을 이용한 유방조직내 흡수선량에 관한 연구", 방사선기술과학, 35(4), pp.345~352 (2012), 대한방사선과학회
- Barca G, "A powerful simulation tool for medical physics applications : Geant4", Nuclear Physics B-Proceedings Supplements, 125, pp.80~84 (2003)
- GEANT4 Collaboration, "GEANT4 developments and applications", IEEE Transactions on Nuclear Science, 53, pp.270~278 (2007)
- Daryoush SB, "Monte Carlo calculation of nine megavoltage photon beam spectra using the BEAM code", Med Phys, 29(3), pp.391~402 (2002)
- Taghavi R, "Claculating the absorbed dose by thyroid in breast cancer radiotherapy using MCNP-4C code", Radiation Physics and Chemistry, 130, pp.12~14 (2017)
- Klein EE, "Task Group 142report : Quality assurance of medical accelerators", Med Phys, 36(9), pp.4197~4212 (2009)
- Rodrigues P, "Application of GEANT4 radiation transport transport toolkit to dose calculations in anthropomorphic phantoms", Applied Radiation and Isotopes, 61(6), pp.1451~1461 (2004)